Header Logo

Connection

HASHEM EL-SERAG to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Aged, 80 and over.
HASHEM EL-SERAG
Connection Strength
2.422
Aged, 80 and over
  1. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019 01; 156(2):477-491.e1.
    View in: PubMed
    Score: 0.070
  2. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3.
    View in: PubMed
    Score: 0.062
  3. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology. 2017 03; 152(4):812-820.e5.
    View in: PubMed
    Score: 0.061
  4. Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy. Clin Gastroenterol Hepatol. 2017 01; 15(1):137-139.
    View in: PubMed
    Score: 0.060
  5. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2017 02; 15(2):273-281.e1.
    View in: PubMed
    Score: 0.060
  6. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat. 2016 09; 23(9):687-96.
    View in: PubMed
    Score: 0.059
  7. Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):301-8.e1-2.
    View in: PubMed
    Score: 0.056
  8. The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15.
    View in: PubMed
    Score: 0.054
  9. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
    View in: PubMed
    Score: 0.054
  10. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett's esophagus. Am J Gastroenterol. 2014 Dec; 109(12):1862-8; quiz 1861, 1869.
    View in: PubMed
    Score: 0.053
  11. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6.
    View in: PubMed
    Score: 0.051
  12. Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. JAMA Intern Med. 2014 Mar; 174(3):462-5.
    View in: PubMed
    Score: 0.051
  13. A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
    View in: PubMed
    Score: 0.050
  14. Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther. 2013 Oct; 38(7):817-24.
    View in: PubMed
    Score: 0.049
  15. Bundling in medicare patients undergoing bidirectional endoscopy: how often does it happen? Clin Gastroenterol Hepatol. 2014 Jan; 12(1):58-63.
    View in: PubMed
    Score: 0.049
  16. The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64.
    View in: PubMed
    Score: 0.048
  17. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):200-3.
    View in: PubMed
    Score: 0.047
  18. Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control. 2013 May; 24(5):1005-14.
    View in: PubMed
    Score: 0.047
  19. Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci. 2013 Jul; 58(7):1967-75.
    View in: PubMed
    Score: 0.047
  20. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
    View in: PubMed
    Score: 0.047
  21. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71.
    View in: PubMed
    Score: 0.046
  22. Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56.
    View in: PubMed
    Score: 0.046
  23. Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012 Oct; 76(4):743-55.
    View in: PubMed
    Score: 0.046
  24. Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288.
    View in: PubMed
    Score: 0.046
  25. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 2012 Jan; 46(1):71-7.
    View in: PubMed
    Score: 0.044
  26. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011 May; 46(5):597-602.
    View in: PubMed
    Score: 0.041
  27. Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther. 2010 Sep; 32(6):712-9.
    View in: PubMed
    Score: 0.040
  28. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010 Jul; 52(1):132-41.
    View in: PubMed
    Score: 0.039
  29. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
    View in: PubMed
    Score: 0.036
  30. Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009 Jan; 29(1):115-25.
    View in: PubMed
    Score: 0.035
  31. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1166-74.
    View in: PubMed
    Score: 0.035
  32. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol. 2007 Nov-Dec; 41(10):911-7.
    View in: PubMed
    Score: 0.033
  33. Temporal trends in new and recurrent oesophageal strictures in a Medicare population. Aliment Pharmacol Ther. 2007 May 15; 25(10):1223-9.
    View in: PubMed
    Score: 0.032
  34. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):87-94.
    View in: PubMed
    Score: 0.030
  35. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006 Jun; 15(6):1198-203.
    View in: PubMed
    Score: 0.030
  36. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006 Jan; 44(1):158-66.
    View in: PubMed
    Score: 0.029
  37. Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci. 2005 Sep; 50(9):1722-8.
    View in: PubMed
    Score: 0.028
  38. Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther. 2005 Jan 01; 21(1):35-41.
    View in: PubMed
    Score: 0.027
  39. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005 Jan; 100(1):162-8.
    View in: PubMed
    Score: 0.027
  40. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004 Nov; 127(5):1372-80.
    View in: PubMed
    Score: 0.027
  41. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004 Apr; 99(4):668-75.
    View in: PubMed
    Score: 0.026
  42. Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45.
    View in: PubMed
    Score: 0.025
  43. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003 Jun; 98(6):1400-9.
    View in: PubMed
    Score: 0.024
  44. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36.
    View in: PubMed
    Score: 0.024
  45. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003 May; 98(5):1186-92.
    View in: PubMed
    Score: 0.024
  46. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002 Sep; 35(3):266-9.
    View in: PubMed
    Score: 0.023
  47. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002 Aug; 37(8):899-904.
    View in: PubMed
    Score: 0.023
  48. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002 Mar; 50(3):368-72.
    View in: PubMed
    Score: 0.022
  49. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001 Feb; 5(1):87-107, vi.
    View in: PubMed
    Score: 0.021
  50. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control. 2021 Apr; 32(4):317-325.
    View in: PubMed
    Score: 0.020
  51. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. Hepatology. 2020 10; 72(4):1242-1252.
    View in: PubMed
    Score: 0.020
  52. Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
    View in: PubMed
    Score: 0.020
  53. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
    View in: PubMed
    Score: 0.019
  54. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019 05; 26(5):596-602.
    View in: PubMed
    Score: 0.018
  55. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11; 340(10):745-50.
    View in: PubMed
    Score: 0.018
  56. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
    View in: PubMed
    Score: 0.018
  57. Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. Clin Gastroenterol Hepatol. 2019 03; 17(4):657-665.e13.
    View in: PubMed
    Score: 0.017
  58. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation. Clin Gastroenterol Hepatol. 2019 01; 17(1):65-72.e5.
    View in: PubMed
    Score: 0.017
  59. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181.
    View in: PubMed
    Score: 0.017
  60. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 08; 16(8):1220-1228.e4.
    View in: PubMed
    Score: 0.017
  61. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018 02; 16(2):252-259.
    View in: PubMed
    Score: 0.016
  62. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
    View in: PubMed
    Score: 0.015
  63. Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
    View in: PubMed
    Score: 0.015
  64. Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia. Dig Dis Sci. 2016 06; 61(6):1714-20.
    View in: PubMed
    Score: 0.014
  65. Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus. Clin Gastroenterol Hepatol. 2016 May; 14(5):769-72.
    View in: PubMed
    Score: 0.014
  66. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1.
    View in: PubMed
    Score: 0.014
  67. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015 Jan; 110(1):10-4.
    View in: PubMed
    Score: 0.013
  68. Patient experiences with surveillance endoscopy: a qualitative study. Dig Dis Sci. 2014 Jul; 59(7):1378-85.
    View in: PubMed
    Score: 0.013
  69. Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014 Mar; 12(3):443-450.e1.
    View in: PubMed
    Score: 0.012
  70. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013 Aug; 108(8):1314-21.
    View in: PubMed
    Score: 0.012
  71. Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci. 2013 Jul; 58(7):2052-60.
    View in: PubMed
    Score: 0.012
  72. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010 Feb; 138(2):513-21, 521.e1-6.
    View in: PubMed
    Score: 0.009
  73. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7.
    View in: PubMed
    Score: 0.008
  74. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 2007 Aug 01; 110(3):660-9.
    View in: PubMed
    Score: 0.008
  75. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther. 2007 Apr 15; 25(8):913-24.
    View in: PubMed
    Score: 0.008
  76. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006 Mar; 130(3):639-49.
    View in: PubMed
    Score: 0.007
  77. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005 Nov 15; 22(10):1005-10.
    View in: PubMed
    Score: 0.007
  78. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005 Nov; 11(11):1370-8.
    View in: PubMed
    Score: 0.007
  79. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005 Mar; 128(3):620-6.
    View in: PubMed
    Score: 0.007
  80. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc. 1996 May; 43(5):463-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.